BCLI’s Stochastic Averages Dip: Analyzing Brainstorm Cell Therapeutics, Inc.’s Stock Performance
The market performance of Brainstorm Cell Therapeutics, Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $1.81 on 08/29/23, with the lowest value for the same timeframe being $0.13, recorded on 10/31/23. 52-week price history of BCLI Stock